Oveisi Niki, Sayre Eric C, Brotto Lori A, Cheng Vicki, Cheng Vienna, Gill Sharlene, Hanley Gillian E, McTaggart-Cowan Helen, Peacock Stuart, Rayar Meera, Srikanthan Amirrtha, Taylor Dani, Barnes Mikaela, De Vera Mary A
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Collaboration for Outcomes Research and Evaluation, University of British Columbia, Vancouver, BC, Canada.
J Natl Cancer Inst. 2025 Sep 1;117(9):1817-1824. doi: 10.1093/jnci/djaf120.
Colorectal cancer (CRC) affects a growing number of females. Our objective was to evaluate the impact of CRC on sexual health outcomes among females, while controlling for age.
We conducted a cohort study using administrative health data from the province of British Columbia (BC) including linked health visits and cancer registry from 1985 to 2017. The cohort included females with CRC (n = 25 402; mean age [SD]: 69.0 [13.1]) and matched controls without CRC (n = 254 020; 69.0 [13.1]) in a 1:10 ratio by age, further stratified by age groups (≤39 years and ≥40 years). Multivariable Cox regression models assessed the associations between CRC and 5 sexual health outcomes (dyspareunia, pelvic inflammatory disease, endometriosis, abnormal bleeding, and premature ovarian failure), adjusting for covariates. Sensitivity analyses focused on females with CRC to explore associations between sociodemographic and cancer-related factors and sexual health outcomes. Tests were 2-sided (statistical significance P <.05).
Females with CRC had higher risks of dyspareunia (HR 1.67; 95% CI = 1.62 to 1.73), pelvic inflammatory disease (HR 3.42; 95% CI = 3.07 to 3.81), and endometriosis (HR 1.95; 95% CI = 1.69 to 2.25) compared to controls. In the ≥40-year group, these associations persisted, while in the ≤39-year group, endometriosis was not associated with CRC, but premature ovarian failure was (HR 1.75; 95% CI = 1.40 to 2.19). In sensitivity analyses, we also observed associations with cancer treatments (surgery, chemotherapy, radiation) and sexual health outcomes.
This population-based study identified associations between CRC and adverse sexual health outcomes among female patients, highlighting the need for targeted interventions and support.
结直肠癌(CRC)影响着越来越多的女性。我们的目标是评估CRC对女性性健康结局的影响,同时控制年龄因素。
我们利用不列颠哥伦比亚省(BC)的行政卫生数据进行了一项队列研究,数据包括1985年至2017年的关联健康就诊记录和癌症登记信息。该队列包括CRC女性患者(n = 25402;平均年龄[标准差]:69.0[13.1])以及按年龄1:10比例匹配的无CRC对照女性(n = 254020;69.0[13.1]),并进一步按年龄组(≤39岁和≥40岁)分层。多变量Cox回归模型评估CRC与5种性健康结局(性交困难、盆腔炎、子宫内膜异位症、异常出血和卵巢早衰)之间的关联,并对协变量进行调整。敏感性分析聚焦于CRC女性患者,以探讨社会人口学和癌症相关因素与性健康结局之间的关联。检验采用双侧检验(统计学显著性P <.05)。
与对照组相比,CRC女性患者发生性交困难(风险比[HR] 1.67;95%置信区间[CI] = 1.62至1.73)、盆腔炎(HR 3.42;95% CI = 3.07至3.81)和子宫内膜异位症(HR 1.95;95% CI = 1.69至2.25)的风险更高。在≥40岁年龄组中,这些关联依然存在,而在≤39岁年龄组中,子宫内膜异位症与CRC无关联,但卵巢早衰与之有关联(HR 1.75;95% CI = 1.40至2.19)。在敏感性分析中,我们还观察到癌症治疗(手术、化疗、放疗)与性健康结局之间的关联。
这项基于人群的研究确定了CRC与女性患者不良性健康结局之间的关联,凸显了针对性干预和支持的必要性。